Preparation and characterization of polybutylcyanoacrylate magnetic nanoparticles

Abstract

Abstract: Objective To Prepare and characterize polybutylcyanoacrylate (PBCA) magnetic nanoparticles.Methods The suspension of PBCA magnetic nanoparticles was prepared by emulsion polymerization method. The particle size, size distri-bution, polydispersity and other parameters were determined by photon correlation spectroscopy and transmission electron microscopy, and the iron content in the nanoparticles by ultraviolet spectroscopy. Results The data of the particle size and size distribution of aqueous decanoic acid stabilized Fe₃O₄ magnetic fluids were acquired, and the influences of concentrations of butylcyanoacrylate (BCA) and Dextran-70 on the particle size and size distribution of PBCA magnetic nanoparticles were characterized. Conclusion We have for the first time successfully prepared stable suspension of PBCA magnetic nanoparti-cles by emulsion polymerization method at pH 6.3-6.4 in aqueous medium.

CLC Number:

R977.6

REN Fei¹, CHEN Jian-hai¹, JIANG Yao-dong², CHEN Zhi-liang¹. Preparation and characterization of polybutylcyanoacrylate magnetic nanoparticles[J]. Journal of Southern Medical University, 2004, 24(02): 161-163,167.

References

[1] 赵卫,曹虹,万成松.纳米技术在生物医学中的应用[J].第一军医大学学报,2002,22(5):461-3.Zhao W, Cao H, Wan CS, et al. Application of nanoparticles in biomedical sciences[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(5): 461-3.
[2] 吴传斌,魏树礼.磁性药物微球制剂的研究进展[J].中国药学杂志(Chin Pharm J),1993,28(6):330-5.
[3] Gupta PK, Hung CT, Lam FC. Album in microspheres Ⅲ: synthesis and characterization of microspheres containing adriamycin and magnetic[J]. Iht J Pharm, 1988, 43(2): 167-70.
[4] 李民勤,徐慧显,何炳林,等.葡聚糖磁性毫微粒的制备[J].高等学校化学学报,1996,17(1):147-50.Li MQ, Xu HX, He BL, et al. Preparation of dextran magnetic nanoparticles[J]. Chem J Chin Univ, 1996, 17(1): 147-50.
[5] 吴传斌,何素梅,高文伟,等.阿霉素磁性明胶微球的制备及特性研究[J].中国医药工业杂志,1994,25(2):63-6.Wu CB, He SM, Gao WW, et al. Preparation and characters of adriamycin magnetic geltin microspheres[J]. Chin J Pharm, 1994,25(2): 63-6.
[6] 张阳德,龚连生.磁性阿霉素白蛋白纳米粒的研制[J].中国现代医学杂志,2001,11(3):1-3.Zhang YD, Gong LS. Preparation and properties of magnetic albumin nanoparticles containing adriamycin[J]. Chin J Mod Med,2001, 11(3): 1-3.
[7] 吴远,叶红军,王家龙,等.丝裂霉素·聚碳酸酯磁性微球的制备及靶向治疗原发性肝癌的实验研究[J].华夏医学,2001,14(3):1-3.Wu Y, Ye HJ, Wang JL, et al. Preparation ofpolycarbonate magnetic microsphere containing MMC and its targeting therapeutic effect on hepatocellular carcinoma[J]. Acta Med Sin, 2001, 14(1): 1-3.
[8] Douglas SJ, Illum L, Davis SS, et al. Particle size and distribution of poly (butyl-2-cyanoacrylate) nanoparticles Ⅰ influence ofphysicochemical factors[J]. J Colloid Interface Sci, 1984, 101(1): 149-58.
[9] Douglas SJ, Illum L, Davis SS, et al. Particle size and distribution of poly(butyl-2-cyanoacrylate) nanoparticles Ⅱ influence of stabilizers[J]. J Colloid Interface Sci, 1985, 103(1): 154-63.
[10] 周祖康.胶体化学基础[M].北京大学出版社,1987.285-7.
[11] 张志荣,廖工铁.聚氰基丙烯酸酯毫微球的研究进展[J].中国药学杂志,1994,29(6):323-6.Zhang ZR, Liao GT. Research development of polyalkylcyanoacrylate (PACA) nanoparticles[J]. Chin Pharm J, 1994, 29(6): 323-6.